webinar
Oct. 27-28, 2025, Boston, MA, USA - Booth 114.
Read More

2,2-Dimethyl-4-oxo-3,8,11,14-tetraoxa-5-azahexadecan-16-yl 4-methylbenzenesulfonate

  CAS No.: 1246999-33-6   Cat No.: BADC-01559   Purity: 95% 4.5  

2,2-Dimethyl-4-oxo-3,8,11,14-tetraoxa-5-azahexadecan-16-yl 4-methylbenzenesulfonate is a linker widely used in antibody-drug conjugates (ADCs).

2,2-Dimethyl-4-oxo-3,8,11,14-tetraoxa-5-azahexadecan-16-yl 4-methylbenzenesulfonate

Structure of 1246999-33-6

Quality
Assurance

Worldwide
Delivery

24/7 Customer
Support
Category
ADC Linker
Molecular Formula
C20H33NO8S
Molecular Weight
447.54
Shipping
Room temperature in continental US; may vary elsewhere
Shipping
Please store the product under the recommended conditions in the Certificate of Analysis.

* For research and manufacturing use only. We do not sell to patients.

Size Price Stock Quantity
-- $-- In stock

Looking for different specifications? Click to request a custom quote!

Capabilities & Facilities

Popular Publications Citing BOC Sciences Products
Synonyms
T-BOc-n-amido-peg4-tos
IUPAC Name
2-[2-[2-[2-[(2-methylpropan-2-yl)oxycarbonylamino]ethoxy]ethoxy]ethoxy]ethyl 4-methylbenzenesulfonate
Canonical SMILES
CC1=CC=C(C=C1)S(=O)(=O)OCCOCCOCCOCCNC(=O)OC(C)(C)C
InChI
InChI=1S/C20H33NO8S/c1-17-5-7-18(8-6-17)30(23,24)28-16-15-27-14-13-26-12-11-25-10-9-21-19(22)29-20(2,3)4/h5-8H,9-16H2,1-4H3,(H,21,22)
InChIKey
NWLAEQSWDZYPBV-UHFFFAOYSA-N
Solubility
Moderately soluble
Shipping
Room temperature in continental US; may vary elsewhere
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Pictograms
Harmful
Signal Word
Warning

2,2-Dimethyl-4-oxo-3,8,11,14-tetraoxa-5-azahexadecan-16-yl 4-methylbenzenesulfonate, a versatile chemical compound, finds wide-ranging applications in biotechnological and pharmaceutical research. Here are four key applications presented with a high degree of perplexity and burstiness:

Polymer Synthesis: Serving as a monomer or functional group in polymer synthesis, this compound plays a pivotal role in producing specialized polymers with distinct properties. These polymers, tailored for specific applications such as drug delivery systems and medical implants, leverage unique mechanical and chemical characteristics. By carefully integrating into polymer structures, it enhances the stability and functionality of the final product, amplifying its utility in various biomedical settings.

Pharmaceutical Intermediate: Positioned at the forefront of pharmaceutical research, this compound acts as a crucial intermediate in the synthesis of a spectrum of pharmaceuticals. Its inherent reactivity and capacity to form intricate molecular structures make it indispensable in driving the development of novel drugs. Pharmaceutical scientists harness its potential to introduce specific functional groups into drug candidates, optimizing their therapeutic effectiveness and bioavailability, heralding advancements in drug discovery and delivery.

Surface Modification: Delving into the realm of materials science, this compound emerges as a key player in surface modification processes aimed at enhancing biocompatibility and mitigating biofouling. By binding to surfaces, it generates a functional layer that thwarts the adherence of undesirable cells and proteins, particularly fundamental in medical devices and implants. This strategic application safeguards material functionality and ensures long-term safety for use in biological environments, underlining its significance in enhancing medical technologies.

Analytical Chemistry: Unveiling its prowess in the realm of analytical chemistry, this compound features prominently in derivatization reactions, enabling precise detection and quantification of analytes. Through the formation of stable derivatives with target compounds, it facilitates their identification using diverse analytical techniques like mass spectrometry and chromatography. This amplifies the sensitivity and specificity of analytical methods, streamlining the process of accurately measuring target compounds within intricate sample matrices, propelling advancements in analytical chemistry methodologies.

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Related Products

Contact our experts today for pricing and comprehensive details on our ADC offerings.

You May Also Be Interested In

From cytotoxin synthesis to linker design, discover our specialized services that complement your ADC projects.

ADC Linker Development Enzyme Cleavable Linker Cathepsin B Cleavable Linker/Peptide Linker Phosphatase Cleavable Linker β-Glucuronide Linker β-Galactosidase Cleavable Linker Sulfatase Cleavable Linker Chemically Cleavable Linker Non-Cleavable Linker Services Acid Cleavable Linker/Hydrazone Linker

Unlock Deeper ADC Insights

Learn more about payload design, linker strategies, and integrated CDMO support through our curated ADC content.

Linkers - A Crucial Factor in Antibody–Drug Conjugates In-Depth Review of ADC Linkers: Types, Mechanisms, and Research Progress New Structural Insights Solve Instability Issues of Maleimide Linkers in ADCs PEG Linkers in Antibody-Drug Conjugates Peptide Linkers in Antibody-Drug Conjugates Disulfide Linkers in Antibody-Drug Conjugates Biotinylation Reagents in Antibody-Drug Conjugates Maleimide Linkers in Antibody-Drug Conjugates Current ADC Linker Chemistry SPDB Linkers in Antibody-Drug Conjugates

Explore More ADC Products

Find exactly what your project needs from our expanded range of ADCs, offering flexible options to fit your timelines and goals.

ADC Cytotoxin

Powerful Targeted Cancer Solutions

ADC  Cytotoxin with Linker

Enhanced Stability And Efficacy

ADC Linker

Precise Conjugation For Success

Antibody-Drug  Conjugates (ADCs)

Maximized Therapeutic Performance

Auristatins

Next-Level Tubulin Inhibition

Calicheamicins

High-Impact DNA Targeting

Camptothecins

Advanced Topoisomerase Inhibition

Daunorubicins / Doxorubicins

Trusted Anthracycline Payloads

Duocarmycins

Potent DNA Alkylation Agents

Maytansinoids

Superior Microtubule Disruption

Pyrrolobenzodiazepines

Ultra-Potent DNA Crosslinkers

Traditional Cytotoxic Agents

Proven Chemotherapy Solutions

Cleavable Linker

Precise Intracellular Drug Release

Non-Cleavable Linker

Exceptional Long-Term Stability

Historical Records: Dov-Val-Dil-OtBu | 2,2-Dimethyl-4-oxo-3,8,11,14,17-pentaoxa-5-azanonadecan-19-yl 4-methylbenzenesulfonate | N-Boc-Dap-Phe-OMe | Satralizumab Linker | 23-Hydroxy-3,6,9,12,15,18,21-heptaoxatricosyl 4-methylbenzenesulfonate | Fmoc-L-Lys(Pentynoyl-DIM)-OH | Fmoc-L-Lys(N3-Gly)-OH | N-[4-(-Carboxycyclohexylmethyl)]maleimide | Poly(oxy-1,2-ethanediyl), α-(2-carboxyethyl)-ω-hydroxy- | Fmoc-L-Lys(N3-Aca-DIM)-OH | 2,2-Dimethyl-4-oxo-3,8,11,14-tetraoxa-5-azahexadecan-16-yl 4-methylbenzenesulfonate
Send Inquiry
Verification code
Inquiry Basket